Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapies for small cell lung cancer: Where do we stand?

Critical reviews in oncology/hematology - 1 Aug 2015

Arcaro Alexandre

Abstract excerpt

Small cell lung cancer (SCLC) accounts for 15% of lung cancer cases and is associated with a dismal prognosis. Standard therapeutic regimens have been improved over the past decades, but without a major impact on patient survival. The development of targeted therapies based on a better understanding of the molecular basis of the disease is urgently needed. At the genetic level, SCLC appears very heterogenous,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Drug Delivery Systems
Share to Lung Cancer Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Mutation

Share to Neoplasm Proteins

Share to Precision Medicine

Share to Small Cell Lung Carcinoma

Source

Identifiers

PMID: 25800975
DOI: 10.1016/j.critrevonc.2015.03.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapies for small cell lung cancer: Where do we stand?PMID 25800975Read ↗

Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel PerspectiveSemantic proximity Read ↗

Origins, genetic landscape, and emerging therapies of small cell lung cancer.Semantic proximity Read ↗

Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilitiesSemantic proximity Read ↗

Molecular subtyping of small cell lung cancer.Semantic proximity Read ↗

Signal pathways and precision therapy of small-cell lung cancerSemantic proximity Read ↗

Small cell lung cancer: Novel treatments beyond immunotherapySemantic proximity Read ↗

Recent advances in the management of non-small cell lung cancerSemantic proximity Read ↗

The molecular pathogenesis of small cell lung cancerSemantic proximity Read ↗

Lung cancer: Biology and treatment options.Semantic proximity Read ↗

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation.Semantic proximity Read ↗

Targeted Therapy for Non-Small Cell Lung Cancer.Semantic proximity Read ↗

SCLC-State of the Art and What Does the Future Have in Store?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.